Assessing and Measuring Nonresponse in Schizophrenia
John M. Kane, MD
How many of your patients with schizophrenia have had ≥ 50% improvement? Here, find out about using measurement-based tools to assess baseline symptoms and measure improvement to help you tailor treatments for your patients.
0.5 Credit [See the entire activity]
Addressing Nonresponse in Schizophrenia
John M. Kane, MD
Are the benefits of prescribing clozapine for your patients with treatment-resistant schizophrenia worth the risks? Learn how patients—perhaps surprisingly—answer this question, and find out about ways to effectively monitor for and then address adverse effects when prescribing clozapine.
0.5 Credit [See the entire activity]





Keyword Search


